GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Inc (NYSE:DCF) » Definitions » Other Stockholders Equity

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Other Stockholders Equity : $-0.00 Mil (As of Feb. 2024)


View and export this data going back to 2017. Start your Free Trial

What is BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Other Stockholders Equity?

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Other Stockholders Equity for the quarter that ended in Feb. 2024 was $-0.00 Mil.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's quarterly Other Stockholders Equity stayed the same from Feb. 2023 ($-0.00 Mil) to Aug. 2023 ($-0.00 Mil) but then declined from Aug. 2023 ($-0.00 Mil) to Feb. 2024 ($-0.00 Mil).

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's annual Other Stockholders Equity declined from Aug. 2021 ($0.00 Mil) to Aug. 2022 ($-0.00 Mil) but then stayed the same from Aug. 2022 ($-0.00 Mil) to Aug. 2023 ($-0.00 Mil).

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Other Stockholders Equity Historical Data

The historical data trend for BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Other Stockholders Equity Chart

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Annual Data
Trend Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Other Stockholders Equity
Get a 7-Day Free Trial - - - - -

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Semi-Annual Data
Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Inc (NYSE:DCF) » Definitions » Other Stockholders Equity
Comparable Companies
DMF HEQ JHS PFD WEA DMO SPE BWG BTA NAZ BLK BX OSTO:INVE A TSX:BN KKR APO BK AMP XSWX:PGHN LSE:III
Traded in Other Exchanges
N/A
Address
c/o BNY Mellon Investment Adviser, Inc., 240 Greenwich Street, New York, NY, USA, 10286
Website
https://www.bnymellonim.com
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Inc is a diversified closed-end management investment company. Its investment objectives are to seek high current income and to return at least the Fund's original NAV to holders of record of common shares on or about the termination date.
Executives
Bushra Mannan other: Director of BNYMIA (1) C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Irene Papadoulis other: Director of BNYMIA (1) C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Ping Jiang other: Dir. of Invest. Oversight (1) C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Bradley J Skapyak officer: President 200 PARK AVENUE, NEW YORK NY 10166
Joseph Martella officer: VP C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10288
Daniel Goldstein officer: VP 240 GREENWICH STREET, NEW YORK NY 10286
Robert J. Pomeroy officer: VP; Investment Adviser C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Vinay Patel other: Head of Finance of Sub-Adviser 200 PARK AVE, NEW YORK CITY NY 10166
Alcentra Ny, Llc other: Sub-Adviser 200 PARK AVENUE, 7TH FLOOR, NEW YORK NY 10166
Brandon Chao other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Laurence Raven other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Ross Curran other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Cathy Bevan other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Daire Wheeler other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Eric Larsson other: Portfolio Mgr of Sub-Adviser C/O ALCENTRA NY LLC, 200 PARK AVENUE, NEW YORK CITY NY 10166